NewsMedicinal CannabisOverseed Becomes First Company To Cultivate Medical Cannabis In...

Overseed Becomes First Company To Cultivate Medical Cannabis In France


As reported by NewsWeed

SIX months after obtaining ANSM (French Agency for the Safety of Health products) approval and raising €2.5 million, Overseed is launching a new research and development program in the cultivation of medical cannabis. 

In doing so it has become the first company to cultivate cannabis for medical purposes in France.

By the end of the year, the biotech firm aims to select five plants on which its first pharmaceutical trials will be initiated.

Research Runs

After receiving its authorisation to legally conduct research on cannabis for therapeutic purposes for the first time, Overseed began its first agronomic phase of phenotyping plants two months ago.

This process aims to select plants with precise agronomic criteria and phytochemical profiles, which will guarantee the stability of production and the reliability of cannabis varieties. 

In the second phase, the production of these varieties will be tested in a controlled climate to ensure the stability and homogeneity of the plants.

This research and development programme, the first of its kind in the country, is due to be completed some time in 2023, coinciding with the completion of an ANSM medical cannabis pilot project. 

Production Runs

By the end of 2022, the Overseed team plans to select five varieties of plants that meet the requirements to start the “pharmaceutical run” phase.

The process of extracting the active ingredients from the cannabis plant will then make it possible to develop new drugs that meet the specifications of the ANSM. 

Overseed will develop its extracts with Stanipharm CDMO, an expert in the production of active ingredients, in particular by supercritical CO2 extraction.

“We are very excited to begin this complex agronomic and scientific process that is critical to future drug development. In the coming months, our experts in genetics and cultivation techniques will be fully invested in bringing to medical research as well as to our partners, all the potential of this plant,”  said Hugues Péribère, founder and CEO of Overseed, in a press release. .

“It is also a further step for the French pharmaceutical industry, its sovereignty and its ability to respond to the many medical uses of cannabis. Through our project, we combine the best French expertise to create an innovative and efficient value chain in the territory. The next few months will be devoted to the search for operating laboratory partners and distributors”.

Latest news

As Its Neighbours Seek Legalisation, Poland’s Medical Cannabis & Hemp Industry Could Also Flourish Next Year

EARLIER this month Czechia’s drug commissioner Jindřich Vobořil announced his intention to submit draft legislation for an adult-use cannabis...

German Prohibitionists Lobby EU, German Medical Cannabis Re-Think, High Court Blow For Irish CBD, Hemp Batteries In Electric Vehicles?

GERMAN opponents of its adult-use cannabis programme are taking their fight to Brussels in a bid to scupper the...

Akanda Pulls Out Of Lesotho Amid Ongoing Legal Battle, Bruce Linton Joins SynBiotic, & Ananda Completes Acquisition

Akanda The NASDAQ-listed international medical cannabis operator announced last week that it will abandon its operations in Lesotho following...

Concerns Grow As Cannabis Sceptic Appointed To Lead Malta’s Adult-Use Reform

ALMOST one year since passing legislation fears are growing the Maltese Government is set to undermine its commitment to...

Brains Bio Receives NSF’s First CBD Certification For EU GMP CBD API

PRESS RELEASE BRAINS Bioceutical Corp ("Brains Bio" or the "Company"), a global leader in EU GMP grade Cannabidiol (CBD) has...

Amsterdam Cannabis Expo 2022 Latest Scam To Target Industry

AN upcoming European cannabis conference, at which 10,000 cannabis companies were purportedly due to visit, is thought to be...

Must read

As Its Neighbours Seek Legalisation, Poland’s Medical Cannabis & Hemp Industry Could Also Flourish Next Year

EARLIER this month Czechia’s drug commissioner Jindřich Vobořil announced...

You might also likeRELATED
Recommended to you